“Western Australia, Queensland, and Ireland Accelerate BioAsia’s Momentum “

Hyderabad, February 17, 2024: BioAsia, Asia’s premier biotechnology and life sciences forum, is proud to announce the expansion of its global network with the addition of new international partners for the 2024 edition. Earlier, Flanders had joined the event as the international region partner. Joining forces with Flanders, BioAsia welcomes Western Australia, Ireland, and Queensland as esteemed partners, further solidifying its position as a leading platform for innovation and collaboration in the life sciences sector.

Ms. Amber- Jade Sanderson, Hon’ble Minister for Health and Mental Health, Western Australia.

 While announcing Global partners, Mr. D Sridhar Babu, Hon’ble Minister for Industries and IT, Government of Telangana said, “It is a great time for life sciences in India, particularly in Telangana. With these new international partnerships, we are taking Telangana to newer heights focussed on economic growth and job creation. But importantly it is about exchanging knowledge, technology transfer to pace up research and innovation.”

 The inclusion of these prestigious regions as global partners underscores BioAsia’s commitment to fostering international cooperation and driving progress in healthcare and biotechnology. With a shared vision of advancing scientific discovery and improving global health outcomes, BioAsia and its partners are poised to create new opportunities for growth and development in the life sciences industry. Each partner brings unique expertise and resources to the table, contributing to BioAsia’s mission of catalysing innovation and driving progress in the pharmaceutical and healthcare sectors.

 Western Australia, renowned for its cutting-edge research and development initiatives, joins BioAsia with a wealth of knowledge in biotechnology and medical innovation. The delegation will be led by Ms. Amber Jade Sanderson, Hon’ble Minister for Health and Mental Health, Western Australia and comprise of about 40 members representing Industry, Research / Academia and Start-ups.

 “We are thrilled to partner with BioAsia 2024, a premier platform for advancing innovation in the life sciences industry. Western Australia’s commitment to healthcare excellence aligns perfectly with Telangana and BioAsia’s mission, and we look forward to leveraging this partnership to drive impactful collaborations and accelerate breakthrough discoveries. Together, we aim to shape the future of healthcare and improve outcomes for patients around the world.” said Ms. Amber- Jade Sanderson, Hon’ble Minister for Health and Mental Health, Western Australia.

 Ireland, a global powerhouse in pharmaceuticals, biotechnology, and medical devices, brings its rich legacy of innovation and entrepreneurship to the BioAsia platform. Ireland’s life sciences sector has a global reputation for operational and innovational excellence with over several leading industry names including  Novartis, AbbVie, Janssen, Pfizer, Sanofi, Lilly, AstraZeneca, MSD, Bristol Myers Squibb and Takeda, who have significant operations contributing to exports of €116+ billion annually.

 Queensland, recognized as a hub for healthcare innovation and excellence, offers BioAsia valuable insights and resources in the fields of biopharmaceuticals, medical technology, and digital health. As a leader in fostering industry-academia partnerships, Queensland’s involvement will undoubtedly bolster BioAsia’s efforts in driving transformative change and breakthrough discoveries.

 Commenting on the partnership, Mr. Jayesh Ranjan, Principal Secretary of the Industries & Commerce and Information Technology, Govt of Telangana said, “BioAsia got scaled at an unprecedent level with every passing year. This year we have Western Australia, Queensland & Ireland coming together as additional partners this year. This will elevate the pace of research through sharing of resources and information exchange as countries come in collaboration. We look forward to the association.”

 “We are thrilled to welcome Western Australia, Ireland, and Queensland as our newest global partners for BioAsia 2024,” said Shakthi M. Nagappan, CEO of BioAsia. “Their participation at BioAsia enhances the diversity and expertise of our vibrant lifesciences ecosystem, enabling us to better serve the needs of our global community and drive meaningful impact in the field of life sciences.”

 With the theme of – “Data & AI: Redefining Possibilities, to deliberate the possibility of reshaping the future of healthtech delivery paradigm in the country.”, BioAsia 2024 is all set to be held between 26th to 28th February 2024 in Hyderabad. Over the three days, prominent industry leaders, distinguished scientists, researchers, and entrepreneurs will come together to discuss humanizing healthcare and will hold constructive discussions on how cross-sectional ecosystems can be integrated, how disruptive technologies can be best utilized, and how we can drive quality healthcare with accessibility and affordability at the forefront in the near future.

BioAsia 2024 to Spotlight Micro, Small, and Medium Enterprises (MSMEs)

Hyderabad, 8th February 2024: BioAsia, Asia’s premier life sciences and Health Tech forum, is proud to announce its partnership with the Ministry of Micro, Small, and Medium Enterprises (MSME), Government of India, for the upcoming 21st edition of the event. Scheduled to take place from February 26 to 28, 2024, in Hyderabad, BioAsia 2024 promises to be a pivotal platform for fostering growth and innovation within the MSME sector.

 The collaboration with the Ministry of MSME underscores BioAsia’s commitment, in line with the Government’s vision, to promoting the growth and development of small and medium-sized enterprises, which play a crucial role in India’s burgeoning life sciences industry. With a dedicated MSME Pavilion featuring leading companies from the sector, BioAsia 2024 offers a unique opportunity for MSMEs to forge key partnerships, expand their businesses, and showcase India’s prowess in the global life sciences arena. Through the Procurement & Market Support (PMS) – Market Access Initiatives of Development and Facilitation Office (DFO), the cost of participation for MSMEs are being subsidized upto 100%.

 Expressing his enthusiasm, Mr. Sridhar Babu, Hon’ble Minister for Industries and Information Technology, Telangana, stated, “The new government in Telangana is dedicated to fostering the growth of MSMEs as the driving force of our economy. BioAsia 2024 will provide a platform for MSMEs to thrive, innovate, and contribute to the advancement of the life sciences sector. Further, I am optimistic that this collaborative endeavour will facilitate the enhancement of technical acumen, bolster infrastructure, and optimize the utilization of shared resources”.

 Mr. Jayesh Ranjan, IAS, Principal Secretary of the Industries & Commerce Department, Government of Telangana, remarked, “Over the preceding two decades, we have observed the participation of numerous global and local players within the healthcare and life science realm as contributors to BioAsia. MSMEs have stood as an indispensable component of BioAsia’s landscape over time, and we take great pleasure i perpetuating our affiliation with the Ministry of Micro, Small, and Medium Enterprises (MSME), Government of India”.

 Mr. D. Chandra Sekhar, Additional Development Commissioner, Development and Facilitation Office (DFO), Hyderabad, articulated, “21st edition of BioAsia, themed ‘Transforming Life Sciences with Data and AI’, is poised to propel the growth prospects for MSME units in India, harnessing its catalyzing investments and global openings within the life sciences domain. Through our engagement and involvement in BioAsia 2024, we anticipate that MSME stakeholders will derive substantial advantages from its elevated prominence within the global healthcare industries.”

 “BioAsia has a legacy of bringing together industry leaders, innovators, and policymakers to drive meaningful change in the healthcare sector. With the inclusion of MSMEs as a focal point, BioAsia 2024 will further strengthen our collective efforts to democratize healthcare and foster innovation for the benefit of society,” said Mr. Shakthi Nagappan, Director (Life Sciences) and CEO (BioAsia).

 Over the years, the event has immensely benefitted from its participant history including the likes of several Nobel Prize winners, Lasker Awardees and eminent industry leaders like Mr. Bill Gates (Chair, Gates Foundation), Mr. Satya Nadella (CEO of Microsoft), Mr. Alex Gorsky (Executive Chairman, Johnson & Johnson), Dr. Vas Narasimhan (CEO, Novartis), Mr. Geoff Martha (Chairman & CEO, Medtronic), besides hosting the Country Ministers and Delegates from Asia, America, Africa, and Europe. Being the first edition post-pandemic, BioAsia 2023 was extremely successful with the virtual participation of more than 3000 global participants from over 50+ Countries.